NASDAQ:CRON

Cronos Group - CRON Price Target & Analyst Ratings

$3.09

-0.49 (-13.69%)

(As of 08/9/2022 05:46 PM ET)

Add

Compare

Today's Range: $3.07
▼
$3.36
50-Day Range: $2.59
▼
$3.58
52-Week Range: $2.57
▼
$7.33

Volume: 3.67 million shs
Average Volume: 2.20 million shs
Market Capitalization: $1.17 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.50

Cronos Group Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 8 Analyst Ratings

Consensus Analyst Price Target

$4.50
45.58% Upside

High Prediction	$7.00
Average Prediction	$4.50
Low Prediction	$3.00

Type	Current 8/9/21 to 8/9/22	1 Month Ago 7/10/21 to 7/10/22	3 Months Ago 5/11/21 to 5/11/22	1 Year Ago 8/9/20 to 8/9/21
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	1 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	1 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$4.50	$4.36	$4.36	$9.13
Predicted Upside	45.58% Upside	22.18% Upside	22.18% Upside	-5.59% Downside

Get Cronos Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

CRON Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRON Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cronos Group Stock vs. The Competition

Type	Cronos Group	Medical Companies	S&P 500
Consensus Rating Score	2.38	2.71	2.50
Consensus Rating	Hold	Buy	Hold
Predicted Upside	44.65% Upside	570.60% Upside	19.18% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 461 61.55% Underperform Votes 288 38.45%	Avg. Outperform Votes 167 66.80% Avg. Underperform Votes 83 33.20%	Avg. Outperform Votes 840 68.68% Avg. Underperform Votes 383 31.32%

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/29/2022	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rahul Sarugaser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$7.00	+122.22%
7/28/2022	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Bottomley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
5/11/2022	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Sector Outperform
3/22/2022	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underweight ➝ Equal Weight	$5.00	+39.66%
3/7/2022	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$4.00 ➝ $3.00	-5.96%
2/22/2022	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$6.50 ➝ $4.00	+13.31%
1/27/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Hold	$5.54 ➝ $3.24	-4.99%
11/18/2021	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$5.00	+0.60%
5/11/2020	Pi Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold	$8.50	+61.29%
3/4/2020	MKM Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$12.00 ➝ $11.00	+106.77%

10/22/2019	Piper Jaffray Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	$18.00 ➝ $12.00	+41.01%
9/5/2019	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tamy Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Market Perform

(Data available from 8/9/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

CRON Price Target - Frequently Asked Questions

What is Cronos Group's consensus rating and price target?: According to the issued ratings of 8 analysts in the last year, the consensus rating for Cronos Group stock is Hold based on the current 1 sell rating, 3 hold ratings and 4 buy ratings for CRON. The average twelve-month price prediction for Cronos Group is $4.50 with a high price target of $7.00 and a low price target of $3.00. Learn more on CRON's analyst rating history.
Do Wall Street analysts like Cronos Group more than its competitors?: Analysts like Cronos Group less than other Medical companies. The consensus rating for Cronos Group is Hold while the average consensus rating for medical companies is Buy. Learn more on how CRON compares to other companies.
Do MarketBeat users like Cronos Group more than its competitors?: MarketBeat users like Cronos Group less than other Medical companies. 61.55% of MarketBeat users gave Cronos Group an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Is Cronos Group being upgraded by Wall Street analysts?: Over the previous 90 days, Cronos Group's stock had 4 upgrades by analysts.
Does Cronos Group's stock price have much upside?: According to analysts, Cronos Group's stock has a predicted upside of 23.64% based on their 12-month price targets.
What analysts cover Cronos Group?: Cronos Group has been rated by Canaccord Genuity Group, Canaccord Genuity Group, CIBC, and Raymond James in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NASDAQ:CRON) was last updated on 8/9/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms